A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.
A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.
Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells.
Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer.
Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace.
Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.
Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.
A new test could help patients with advanced bowel cancer get the best treatment for their disease.